In the study, participants receive one booster dose of the vaccine in the muscle. The study then follows how the body responds over the next days after the booster. Blood samples are taken during the study to check for signs of protection, and any side effects such as pain, redness, swelling, headache, fever, or tiredness are recorded. The study compares the three earlier vaccination plans to see which one gives a strong response after the booster.

The purpose of the study is to estimate the level of pain children feel after receiving the vaccine. The study will involve giving the vaccine using different methods, such as injecting it into the skin (intradermal) or into the muscle (intramuscular). The study will also look at how easy and safe these methods are to use. Children participating in the study will receive the vaccine and their pain levels will be measured using a special scale designed for children. Parents or guardians will also provide their observations on the child’s pain and the usability of the injection methods.

The study will monitor the children for any side effects after the vaccination and will check if the vaccine successfully helps the body produce enough antibodies to protect against rabies. The study aims to provide valuable information on the best ways to administer the rabies vaccine to children, ensuring both effectiveness and comfort.

The purpose is to assess how well the body’s immune system remembers and responds to the rabies vaccine five years after receiving a single dose. The study involves comparing the effectiveness of a single-dose vaccination approach to a traditional two-dose vaccination schedule. Participants will receive vaccine injections and have their blood tested to measure their immune response.

The study will track participants over a five-year period. During this time, participants will receive either a single dose or two doses of the vaccine initially, followed by additional doses after five years to simulate an exposure situation. The immune system’s response will be measured through blood tests that look for protective antibodies against the rabies virus.

Participants in the study will receive the vaccine in one of these two ways during a single visit. The study will then monitor the participants to see how well their bodies respond to the vaccine by measuring the level of protective antibodies against rabies in their blood. These antibodies are proteins made by the immune system to help fight infections. The study will check these levels at different times after the vaccination to see how well the vaccine works over time.

The study aims to determine if the new methods of giving the vaccine are as effective as the standard method currently used. This will be assessed by looking at how many participants have enough antibodies to protect against rabies after receiving a booster dose of the vaccine. The study will also look at the safety of the vaccine when given in these new ways, ensuring that it does not cause any unexpected side effects. The trial is expected to continue until 2025, with the goal of improving rabies prevention strategies.

The purpose of the study is to understand how these two methods of vaccination affect the body’s immune response, particularly focusing on a type of immune cell called T cells. These cells are important for fighting infections. The study will measure the number of these cells that remain in the skin after vaccination, as well as other immune responses over time. Participants will receive either the intradermal or intramuscular vaccine and will be monitored for changes in their immune system.

The study will take place over several months, with participants receiving a series of vaccinations and follow-up visits to monitor their immune response. The goal is to determine which method of vaccination is more effective in producing a strong and lasting immune response against rabies. This information could help improve rabies vaccination strategies in the future.